Filing Details

Accession Number:
0000891293-12-000040
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-06-29 19:54:19
Reporting Period:
2012-06-27
Filing Date:
2012-06-29
Accepted Time:
2012-06-29 18:54:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
891293 Cell Therapeutics Inc CTIC Pharmaceutical Preparations (2834) 911533912
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1355850 G Daniel Eramian 3101 Western Avenue, Suite 600
Seattle WA 98121
Evp, Corporate Communications No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-06-27 27,415 $0.00 1,991,761 No 4 A Direct
Common Stock Disposition 2012-06-28 3,000 $0.57 1,988,761 No 4 S Direct
Common Stock Disposition 2012-06-28 200 $0.57 1,988,561 No 4 S Direct
Common Stock Disposition 2012-06-28 6,800 $0.57 1,981,761 No 4 S Direct
Common Stock Disposition 2012-06-28 9,731 $0.57 1,972,030 No 4 S Direct
Common Stock Disposition 2012-06-28 269 $0.57 1,971,761 No 4 S Direct
Common Stock Disposition 2012-06-28 10,000 $0.58 1,961,761 No 4 S Direct
Common Stock Disposition 2012-06-28 20,000 $0.58 1,941,761 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. As disclosed by CTIC in a Form 8-K filed on 12/1/11, CTIC granted a bonus opportunity to the reporting person that is payable in shares of CTIC stock upon the achievement of certain performance goals. The shares reported above on this Form 4 reflect the issuance of vested stock by CTIC pursuant to the award in connection with the achievement of the Pixantrone MAA Approval goal under the award.